CBD Gummies UK Regulations – Understanding the Rules
CBD gummies are sold as food products, which means their regulatory position is different from that of medicines or other types of cannabinoid products.
In the UK, CBD used in foods is treated as a novel food, and businesses need to consider the regulatory requirements that apply to the market in which their products are sold.
However, terms such as novel food, validated, authorised, FSA listed and FSS regulated can easily be misunderstood.
They do not all mean the same thing.
There is also an important geographical distinction. The Food Standards Agency’s public list of CBD products applies to England and Wales, while Food Standards Scotland (FSS) is responsible for food regulation in Scotland.
This guide explains the current position and what these regulatory terms actually mean when considering CBD gummies in the UK.
What Is a Novel Food?
A novel food is broadly a food or food ingredient that did not have a significant history of consumption before the relevant regulatory cut-off date.
For CBD, the novel-food status of CBD extracts was confirmed in January 2019. Current FSA guidance states that CBD extracts, CBD isolates, synthetic CBD products and foods to which these are added as ingredients are classed as novel foods.
That includes food formats such as CBD confectionery and gummies.
Novel-food regulation exists so that new food ingredients can undergo safety assessment before being authorised for use under specified conditions.
An important distinction is therefore:
Novel food ≠ prohibited food
and equally:
Novel food ≠ automatically authorised food
The regulatory status depends upon the applicable authorisation process and transitional arrangements.
“Novel food” describes a regulatory category — it is not a quality rating or product endorsement.”
What Is the FSA CBD Public List?
The FSA maintains a public register of CBD food products linked to novel-food applications.
The current FSA criteria state that products on the list are linked to applications where:
- the products were on the market by the relevant February 2020 point;
- an application was received by the required March 2021 deadline; and
- the application was validated or was considered sufficiently progressing towards validation.
Importantly:
Being on the FSA list is not the same as receiving novel-food authorisation.
The FSA describes the public list as an interim measure used while CBD applications progress through the novel-food process. Its September 2026 board material explicitly says that products on the public list remain unauthorised novel foods, with enforcement decisions resting with local authorities.
This distinction is absolutely worth emphasising because consumers can understandably interpret “FSA listed” as meaning “FSA approved”.
Those are not equivalent statements.
What Does “Validated” Mean for a CBD Novel-Food Application?
The term validated has a specific meaning within the novel-food application process and should not be confused with approval or authorisation.
The Food Standards Agency explains that validation involves checking that an application contains the information required by law to allow it to proceed through the authorisation process. This includes the evidence required for a risk assessment. Once an application has been validated at this initial stage, it can proceed to the risk-assessment phase.
Validation therefore indicates that an application has successfully reached an important procedural stage. It does not, by itself, mean that the CBD food has received final novel-food authorisation.
Validated does not mean authorised.
This distinction is particularly important because consumers may reasonably interpret words such as validated, listed, approved and authorised as meaning broadly the same thing.
From a regulatory perspective, they should not be used interchangeably.
Validation and authorisation are different stages of the novel-food process.
Is an FSA-Listed CBD Product “FSA Approved”?
No.
The FSA’s CBD Public List identifies CBD food products linked to novel-food applications that meet the criteria established for inclusion on that list.
Those criteria include that the product was on the market by 13 February 2020, that an application was received before 31 March 2021, and that the application was either validated or considered sufficiently progressing towards validation.
However, inclusion on the FSA CBD Public List should not be presented as equivalent to formal novel-food authorisation.
The FSA also explicitly states that it is not endorsing the sale of CBD food products simply because they appear on the list.
FSA listed ≠ FSA approved or endorsed
This is why terminology matters. Describing a product accurately according to its actual regulatory status is preferable to using broader phrases that could give consumers the impression that a product has received an approval or endorsement that has not occurred.
Are Any CBD Novel Foods Currently Authorised?
Information checked: September 2026
Food Standards Scotland currently states that CBD foods require pre-market safety assessment and authorisation by Scottish Ministers and that no CBD food products have yet been authorised as novel foods in Scotland.
However, the authorisation process is progressing.
In March 2026, Food Standards Scotland opened consultation on the first three CBD novel-food applications seeking authorisation in Scotland. That consultation closed on 16 June 2026, with responses intended to inform recommendations to Scottish Ministers.
As of 16 September 2026, FSS Board papers also include recommendations to ministers concerning the first CBD novel-food authorisations.
Check official registers for updates before going live
Does a Certificate of Analysis Mean a CBD Gummy Is Authorised?
No.
A Certificate of Analysis and novel-food authorisation provide completely different types of information.
A Certificate of Analysis (CoA) provides analytical information concerning the particular material or sample identified on the laboratory documentation.
Novel-food authorisation concerns whether a novel food has completed the applicable regulatory process and has been authorised for use under specified conditions.
Laboratory testing ≠ regulatory authorisation
and:
Certificate of Analysis ≠ novel-food authorisation
For a detailed explanation of Certificates of Analysis, ingredient testing, finished-gummy testing, batch references and traceability, see:
CBD Gummy Testing & Traceability (Planet 7)
Does “THC-Free” Mean a CBD Gummy Is Authorised?
No.
THC-related terminology and novel-food authorisation concern different aspects of a CBD product.
A THC-related statement concerns the cannabinoid characteristics of the relevant ingredient or product and the evidence supporting that statement.
Novel-food authorisation concerns its regulatory status.
Therefore, evidence supporting a THC-free position does not, by itself, establish that a CBD food has received novel-food authorisation.
Likewise, regulatory status does not tell a consumer what a laboratory found when analysing a particular sample for THC.
For a detailed explanation of THC terminology, analytical detection and what THC-free actually means:
THC-Free CBD Gummies (Planet 6)
Does CBD Isolate Have a Different Regulatory Status Because It Is Highly Purified?
The purity of CBD isolate and its regulatory status are separate considerations.
CBD isolate may be a highly purified cannabinoid ingredient, but its purity does not remove it from the novel-food framework.
Food Standards Scotland specifically states that businesses seeking authorisation for CBD extracts, isolates and associated products use the regulated-product application process.
High-purity CBD isolate ≠ exemption from novel-food requirements
For a detailed explanation of what CBD isolate is and how it differs from other CBD formulations:
CBD Isolate Gummies (Planet 5)
What Is the Current CBD Daily-Intake Advice?
Current Food Standards Scotland guidance recommends that healthy adults limit consumption of CBD from food and drink to no more than 10mg per day.
This is important when interpreting an Incr-edibles gummy containing 25mg CBD.
25mg per gummy = the CBD content of the product
10mg per day = current consumer intake guidance for healthy adults from CBD food and drink
These figures describe different things.
The 25mg content of an individual gummy should therefore not be presented as though it represents the recommended daily amount.
For the practical-use discussion:
How to Take CBD Gummies (Planet 2)
For the distinction between 25mg per gummy and the total CBD contained within the 15- and 30-gummy packs:
CBD Gummies Strength & Pack Sizes (Planet 4)
Who Should Be Particularly Cautious About CBD Foods?
Current Food Standards Scotland advice states that CBD is not recommended for vulnerable groups unless under medical direction. Its current guidance identifies these groups as:
- children and young people under 18;
- people who are pregnant or breastfeeding;
- people trying to conceive;
- people taking medication; and
- people who are immunosuppressed.
Because this is official consumer-safety advice and may be updated as the regulatory process develops, I recommend linking visitors directly to the current Food Standards Scotland guidance rather than trying to make Planet 8 the permanent definitive source.
Food Standards Scotland – Cannabidiol (CBD) Consumer guidance
Are CBD Gummies Medicines?
CBD gummies sold as food products should not automatically be presented as medicines.
Food regulation and medicines regulation are separate regulatory frameworks.
Food Standards Scotland states that it has regulatory responsibility for CBD used in food products, while the medicinal use of CBD falls within the remit of the Medicines and Healthcare products Regulatory Agency (MHRA).
Therefore, the fact that a CBD gummy falls within food and novel-food requirements does not mean that it has been authorised as a medicine.
What Should Consumers Look for When Assessing CBD Gummies?
Rather than relying upon a single phrase such as “FSA approved”, “legal CBD”, “validated” or “lab tested”, consumers can consider the different questions separately:
- What type of CBD ingredient is being used?
- How much CBD does the product contain?
- What does the supporting analytical documentation actually relate to?
- Can relevant ingredient and batch information be traced?
- How is the product’s regulatory position described?
- Is “validated” being distinguished from “authorised”?
- Is the distinction between England and Wales and Scotland being made where relevant?
- Are analytical and regulatory statements being presented accurately rather than as endorsements?
Considering these points separately provides a clearer picture than relying upon a single regulatory-sounding phrase.
How Does Incr-edibles Approach CBD Regulatory Information?
At Incr-edibles, we believe regulatory terminology should be presented according to what it actually means.
We therefore distinguish between CBD ingredient information, analytical testing, novel-food application status, FSA Public List information and formal novel-food authorisation, rather than presenting these different concepts as though they were interchangeable.
We also recognise that the regulatory position needs to be described according to the market concerned.
The FSA’s CBD Public List applies to England and Wales only, while Food Standards Scotland has regulatory responsibility for CBD used in food products in Scotland.
As the CBD novel-food authorisation process continues to develop, the regulatory information presented on this page should be reviewed against current official FSA and FSS information.
Frequently Asked Questions About CBD Gummies UK Regulations
Ask Dave to draw up a table for this
Are CBD gummies legal in the UK?
CBD gummies sold as food fall within food-law and novel-food requirements. Their regulatory position depends on the applicable jurisdiction, novel-food status, and relevant authorisation or interim arrangements. Consumers should not assume that every CBD gummy has the same regulatory status.
Are CBD gummies novel foods?
Foods containing CBD extracts or isolates fall within the novel-food framework and require the appropriate safety assessment and authorisation. Food Standards Scotland (FSS) identifies foods containing CBD among its examples of novel foods.
What does FSA listed mean for CBD gummies?
The FSA Public List identifies CBD food products linked to novel-food applications that meet its specified criteria. The list applies to England and Wales only.
Does FSA listed mean FSA approved?
No. The FSA explicitly states that it is not endorsing the sale of CBD food products simply because they appear on the list.
What does validated mean for CBD?
Validation means the application contains the information required by law to allow it to proceed through the authorisation process, including the necessary evidence for risk assessment.
Is validated the same as authorised?
No. Validation and authorisation represent different stages of the regulatory process.
Who regulates CBD foods in Scotland?
Food Standards Scotland has regulatory responsibility for CBD used in food products in Scotland.
Does a CoA prove that CBD gummies are authorised?
No. A CoA provides analytical information concerning the identified sample or material. Novel-food authorisation is a separate regulatory process. (See also: CBD Gummy Testing & Traceability)
Does THC-free mean a CBD gummy is authorised?
No. THC status and novel-food regulatory status concern different characteristics of a product. (See also: THC-Free CBD Gummies)
Have CBD novel foods been authorised in Scotland?
At the time this page was checked in September 2026, FSS states that no CBD food products have yet been authorised as novel foods in Scotland. The first applications have, however, progressed substantially through the regulatory process, so this position should be checked against current FSS information.